Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
Clinical trial NCT05548270 · COMPLETED
Trial details
- NCT number
- NCT05548270
- Sponsor
- Repurposed Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2022-11-29
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.